Search - tctmd.com

Displaying 1 - 20 of 40

Sort: Relevancy | Date

Presentation TVT 2016

Three Interesting TAVR Valve-in-Valve Cases

Presenter: Isaac George

June 17, 2016

Presentation TVT 2016

Optimal Use Recommendations for Self-Expanding and Balloon-Expandable TAVR to Treat Aortic Bioprosthetic Valve Failure

Presenter: Mathew Williams

June 17, 2016

Presentation TVT 2016

The Essential Take-home Messages From the VIVID Registry on TAVR for Aortic Bioprosthetic Valve Failure

Presenter: Danny Dvir

June 17, 2016

Presentation TVT 2016

Anatomy of Surgical Bioprosthetic Valves and a How-to Primer on the Valve-in-Valve App

Presenter: Vinayak Bapat

June 17, 2016

Presentation TVT 2016

TAVR-Related Endocarditis: Incidence, Clinical Relevance, and Management

Presenter: Bernard Prendergast

June 17, 2016

Presentation TVT 2016

An Update on Subclinical Bioprosthetic Leaflet Thickening and Thrombosis: Possible Effects on TAVR Durability

Presenter: Raj Makkar

June 17, 2016

Presentation TVT 2016

The Incidence, Diagnosis, Impact, and Treatment of Valve Thrombosis After TAVR

Presenter: Azeem Latib

June 17, 2016

Presentation TVT 2016

PARTNER Echocardiography Observations on Valve Durability

Presenter: Rebecca T. Hahn

June 17, 2016

Presentation TVT 2016

A Surgeons Perspective on Bioprosthetic Valve Durability and Structural Valve Deterioration

Presenter: Hendrik Treede

June 17, 2016

Presentation TVT 2016

Left Main Coronary Disease and AS: Management Approaches With Case Examples

Presenter: Raj Makkar

June 17, 2016

Presentation TVT 2016

Strategies and Timing of PCI in Patients With CAD Undergoing TAVR: Results From a Large Single-Center Experience

Presenter: Torsten P. Vahl

June 17, 2016

Presentation TVT 2016

Replacing the Valve Is Usually Sufficient to Manage Severe AS and Coronary Disease

Presenter: Mark J. Russo

June 17, 2016

Presentation TVT 2016

Acute Coronary Syndrome in AS Patients: Guidelines for the Practitioner

Presenter: Raj Makkar

June 17, 2016

Presentation TVT 2016

Stable Coronary Disease in AS Patients: Evolving Treatment Considerations (Indications for CABG vs PCI, Hybrid Approaches, and Completeness of Revascularization)

Presenter: James B. Hermiller Jr

June 17, 2016

Presentation TVT 2016

An Update on Transcaval TAVR: Case Selection, Technique, and Outcomes

Presenter: Adam B. Greenbaum

June 16, 2016

Presentation TVT 2016

The Reemergence of Transcarotid TAVR as a Worthwhile Alternative

Presenter: David J. Cohen

June 16, 2016

Presentation TVT 2016

Is Subclavian-Axillary TAVR the Preferred Alternative?

Presenter: A. Pieter Kappetein

June 16, 2016

Presentation TVT 2016

Advantages and Technique Recommendations for Direct Aortic Access for TAVR

Presenter: Vinayak Bapat

June 16, 2016

Presentation TVT 2016

Transapical TAVR Remains a Worthwhile and Necessary Alternative: Results in a High-Volume Center and Optimal Technique

Presenter: Thomas Walther

June 16, 2016

Presentation TVT 2016

Be Prepared! The Management of Vascular Complications After Transfemoral TAVR

Presenter: James M. McCabe

June 16, 2016

Advertisement

Three Interesting TAVR Valve-in-Valve Cases

Optimal Use Recommendations for Self-Expanding and Balloon-Expandable TAVR to Treat Aortic Bioprosthetic Valve Failure

The Essential Take-home Messages From the VIVID Registry on TAVR for Aortic Bioprosthetic Valve Failure

Anatomy of Surgical Bioprosthetic Valves and a How-to Primer on the Valve-in-Valve App

TAVR-Related Endocarditis: Incidence, Clinical Relevance, and Management

An Update on Subclinical Bioprosthetic Leaflet Thickening and Thrombosis: Possible Effects on TAVR Durability

The Incidence, Diagnosis, Impact, and Treatment of Valve Thrombosis After TAVR

PARTNER Echocardiography Observations on Valve Durability

A Surgeons Perspective on Bioprosthetic Valve Durability and Structural Valve Deterioration

Left Main Coronary Disease and AS: Management Approaches With Case Examples

Strategies and Timing of PCI in Patients With CAD Undergoing TAVR: Results From a Large Single-Center Experience

Replacing the Valve Is Usually Sufficient to Manage Severe AS and Coronary Disease

Acute Coronary Syndrome in AS Patients: Guidelines for the Practitioner

Stable Coronary Disease in AS Patients: Evolving Treatment Considerations (Indications for CABG vs PCI, Hybrid Approaches, and Completeness of Revascularization)

An Update on Transcaval TAVR: Case Selection, Technique, and Outcomes

The Reemergence of Transcarotid TAVR as a Worthwhile Alternative

Is Subclavian-Axillary TAVR the Preferred Alternative?

Advantages and Technique Recommendations for Direct Aortic Access for TAVR

Transapical TAVR Remains a Worthwhile and Necessary Alternative: Results in a High-Volume Center and Optimal Technique

Be Prepared! The Management of Vascular Complications After Transfemoral TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content